Latest Capital Raises News

Dotz Nano Limited has raised approximately A$2 million through a private placement, reinforcing its position in the emerging carbon capture market with fresh capital and new investors.

Micro-X Limited has secured $6 million through a share placement to accelerate commercialisation of its innovative medical imaging technologies, with strategic partner Billion Prima increasing its stake to 8.5%. The capital raise supports key clinical trials and product development milestones.

Micro-X has raised $6.18 million through a placement that sees strategic partner Billion Prima increase its stake to 8.6%, funding key commercial and manufacturing scale-up initiatives in medical imaging.

IRIS Metals Limited has had its trading suspension lifted following the announcement of a new transaction and an update on its capital raising efforts, signaling renewed momentum for the base metals miner.

IRIS Metals has signed a binding agreement to farm-in exclusively to the Finley Basin Tungsten Project in Montana, expanding its critical minerals portfolio and cancelling a planned capital raise. Exploration is set to begin in early 2026 with resource estimation targeted for 2027.

Cleo Diagnostics has raised $5 million to support the U.S. commercial launch of its Pre-Surgical Ovarian Cancer Test and accelerate development of a mass screening test, signaling strong investor confidence in its technology.

Mount Ridley Mines has locked in nearly $1.8 million through a fully underwritten exercise of expiring unlisted options, ensuring financial backing for its Mount Ridley Project exploration and metallurgical programs.

Memphasys Limited’s partner International Technical Legacy has placed an early order for 500 Felix™ cartridges ahead of anticipated CE Mark approval, signalling strong clinic demand and validating the company’s direct-selling strategy in the Middle East.

Resource Minerals International Ltd has successfully raised $1 million through a share placement to fund exploration projects across Saudi Arabia, Tanzania, and Finland, while also achieving a debt-free status.

Paladin Energy has restructured its syndicated debt facility, reducing total debt capacity from US$150 million to US$110 million, enhancing liquidity and balance sheet flexibility following a strong equity raise in 2025.

BlinkLab Limited has appointed its Co-Founder and CEO, Dr Henk-Jan Boele, as Managing Director to steer the company through its pivotal FDA 510(k) trial for its autism diagnostic technology. The move coincides with key board changes and signals a strategic shift as BlinkLab prepares for early commercialisation.

The Calmer Co. International Limited has completed a $1.4 million convertible note raise, positioning itself to accelerate wholesale growth and inventory build ahead of 2026.